“First, do no harm” calls for thoughtful physician-patient dialogue, not fear - STAT

“First, do no harm” calls for thoughtful physician-patient dialogue, not fear - STAT

“First, do no harm” calls for thoughtful physician-patient dialogue, not fear

Delivering the best possible care while ensuring patient safety is the ultimate goal in health care. Yet, recent media reports about the safety of medical devices and drug-free pain management therapies can undermine quality care by deterring patients from open discussions with their doctors about potentially beneficial treatments. Health care reporting should equip patients for those conversations — not scare them away. Learn more. 

Phase 3 Trial of Rova-T as Second-line Therapy for Advanced Small-Cell Lung Cancer (TAHOE STUDY) Halted

- Independent Data Monitoring Committee responsible for ongoing review of study data recommended enrollment be stopped

https://www.prnewswire.com/news-releases/phase-3-trial-of-rova-t-as-second-line-therapy-for-advanced-small-cell-lung-cancer-tahoe-study-halted-300760918.html?utm_source=STAT+Newsletters&utm_campaign=e0cce7ef73-MR_COPY_03&utm_medium=email&utm_term=0_8cab1d7961-e0cce7ef73-149692869